USANA Health Sciences Balance Sheet

Financials in millions USD. Fiscal year is February - January.

Millions USD. Fiscal year is Feb - Jan.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '26 Jan 3, 2026	Dec '24 Dec 28, 2024	Dec '23 Dec 30, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
Cash & Equivalents	158.38	181.77	330.42	288.42	239.83
Cash & Short-Term Investments	158.38	181.77	330.42	288.42	239.83
Cash Growth	-12.87%	-44.99%	14.56%	20.26%	-23.11%
Other Receivables	-	8.22	7.2	7.21	7.16
Receivables	-	8.22	7.2	7.21	7.16
Inventory	102.61	69.74	61.45	67.09	98.32
Prepaid Expenses	27.42	13.76	11.39	11.38	13.85
Other Current Assets	-	5.7	7.28	10.28	5.95
Total Current Assets	288.41	279.19	417.75	384.38	365.12
Property, Plant & Equipment	94.38	111.12	107.68	111.69	120.07
Long-Term Investments	-	20	-	-	-
Goodwill	137.96	144.17	17.1	17.37	17.67
Other Intangible Assets	133.15	151.82	29.92	32.43	30.44
Long-Term Deferred Tax Assets	27.21	19.64	13.28	9.8	4.84
Other Long-Term Assets	61.81	22.25	47.03	40.88	39.6
Total Assets	742.92	748.19	632.76	596.55	577.74
Accounts Payable	17.26	11.98	10.07	11.05	13.51
Accrued Expenses	-	79.57	80.84	84.26	97.63
Short-Term Debt	14	23	0.79	-	-
Current Portion of Leases	-	6.01	7.28	6.89	7.08
Current Income Taxes Payable	-	3.71	3.3	4.97	5.19
Current Unearned Revenue	-	12.05	13.91	20.88	19.64
Other Current Liabilities	97.3	3.3	2.66	15.79	17.75
Total Current Liabilities	128.57	139.63	118.85	143.83	160.79
Long-Term Leases	-	10.19	5.14	7.68	10.22
Long-Term Deferred Tax Liabilities	4.89	4.07	4.55	4.07	7.5
Other Long-Term Liabilities	23.19	7.97	7.02	6.49	4.11
Total Liabilities	156.64	161.86	135.56	162.08	182.62
Common Stock	533.1	0.02	0.02	0.02	0.02
Additional Paid-In Capital	-	75.82	65.66	55.6	50.01
Retained Earnings	-	478.94	445.22	391.64	344.64
Comprehensive Income & Other	-	-22.67	-13.7	-12.79	0.46
Total Common Equity	533.1	532.11	497.2	434.47	395.12
Minority Interest	53.17	54.22	-	-	-
Shareholders' Equity	586.27	586.33	497.2	434.47	395.12
Total Liabilities & Equity	742.92	748.19	632.76	596.55	577.74
Total Debt	14	39.2	13.21	14.57	17.3
Net Cash (Debt)	144.38	142.56	317.22	273.85	222.54
Net Cash Growth	1.27%	-55.06%	15.84%	23.06%	-23.38%
Net Cash Per Share	7.77	7.44	16.40	14.18	10.94
Filing Date Shares Outstanding	18.3	18.9	19.24	19.29	19.32
Total Common Shares Outstanding	18.3	19.06	19.13	19.21	19.39
Working Capital	159.84	139.56	298.9	240.55	204.33
Book Value Per Share	29.13	27.91	25.99	22.62	20.37
Tangible Book Value	261.99	236.12	450.18	384.67	347.01
Tangible Book Value Per Share	14.31	12.39	23.53	20.03	17.89
Land	-	6.36	6.72	6.72	6.99
Buildings	-	76.68	77.8	78.07	80.82
Machinery	-	121.16	116.82	113.99	111.47
Leasehold Improvements	-	12.61	14.34	14.39	15.21

Source: S&P Global Market Intelligence. Standard template. Financial Sources.